Time-Dependent Changes in Factors Involved in the Apoptotic Process in Human Ovarian Cancer Cells as a Response to Cisplatin
- 1 March 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (3) , 404-412
- https://doi.org/10.1006/gyno.2001.6537
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mechanisms of drug resistance in ovarian cancerCancer, 2010
- Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to CisplatinJournal of Biological Chemistry, 2000
- Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosisOncogene, 1999
- Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53International Journal of Cancer, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature, 1995
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Cell Cycle Perturbations of Platinum Derivatives on Two Ovarian Cancer Cell LinesCancer Investigation, 1993
- Prediction of Response to Drug Therapy of CancerDrugs, 1992